Literature DB >> 17408953

Beta-substituted cyclohexanecarboxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic core.

Joël Robichaud1, Christopher I Bayly, W Cameron Black, Sylvie Desmarais, Serge Léger, Frédéric Massé, Daniel J McKay, Renata M Oballa, Julie Pâquet, M David Percival, Jean-François Truchon, Gregg Wesolowski, Sheldon N Crane.   

Abstract

Further SAR study around the central 1,2-disubstituted phenyl of the previously disclosed Cat K inhibitor (-)-1 has demonstrated that the solvent exposed P2-P3 linker can be replaced by various 5- or 6-membered heteroaromatic rings. While some potency loss was observed in the 6-membered heteroaromatic series (IC(50)=1 nM for pyridine-linked 4 vs 0.5 nM for phenyl-linked (+/-)-1), several inhibitors showed a significantly decreased shift in the bone resorption functional assay (10-fold for pyridine 4 vs 53-fold for (-)-1). Though this shift was not reduced in the 5-membered heteroaromatic series, potency against Cat K was significantly improved for thiazole 9 (IC(50)=0.2 nM) as was the pharmacokinetic profile of N-methyl pyrazole 10 over our lead compound (-)-1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408953     DOI: 10.1016/j.bmcl.2007.03.028

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Carbon-11 labeled cathepsin K inhibitors: syntheses and preliminary in vivo evaluation.

Authors:  Melissa E Rodnick; Xia Shao; Kenneth M Kozloff; Peter J H Scott; Michael R Kilbourn
Journal:  Nucl Med Biol       Date:  2014-02-18       Impact factor: 2.408

Review 2.  Advances in the discovery of cathepsin K inhibitors on bone resorption.

Authors:  Jun Lu; Maolin Wang; Ziyue Wang; Zhongqi Fu; Aiping Lu; Ge Zhang
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.